Diebold Nixdorf, Incorporated
Diebold Nixdorf, Incorporated (DBD) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · DBD · as of Jun 8, 2026
Key Statistics
Explore Diebold Nixdorf, Incorporated Data
dbd stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 13 · Buy rate: 38.5%
The DBD analyst consensus is Buy, based on ratings from 13 Wall Street analysts over the past 3 months. The average 12-month price target is $100.00, representing +23.24% upside from the current price of $81.14.
Competitors & Peers
dbd competitorsDBD
ALKT
ALRM
APPN
CXM
EVCMStock Performance
Full HistoryAbout Diebold Nixdorf, Incorporated
Diebold Nixdorf, Incorporated engages in the automating, digitizing, and transforming the way people bank and shop worldwide. It operates through two segments, Banking and Retail. The company offers c…
what is diebold nixdorf, incorporated · dbd stock overview · diebold nixdorf, incorporated company profile · who is diebold nixdorf, incorporated ceo · dbd NYSE · diebold nixdorf, incorporated headquarters · diebold nixdorf, incorporated business segments
About Stock Overview & Key Data
Diebold Nixdorf, Incorporated (DBD) is a Technology company in the Software - Application industry, listed on NYSE since Aug 14, 2023. As of the latest trading session, DBD stock price is $81.14, with a market capitalization of $2.8B. The stock has returned +58.41% over the past 12 months and +19.52% year-to-date.
According to 13 Wall Street analysts, the consensus rating for Diebold Nixdorf, Incorporated stock is Buy, with an average 12-month price target of $100.00. In fiscal year 2025, Diebold Nixdorf, Incorporated reported revenue of $3.8B and net income of $94.6M. For detailed data — including Diebold Nixdorf, Incorporated revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Diebold Nixdorf, Incorporated (DBD) stock price is $81.14. The stock is traded on NYSE under the ticker symbol DBD. The 52-week range is $49.15 – $89.05.